Helix BioPharma Corp. Initiates Enrollment for Thirteenth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47

… to patients with non-small cell lung cancer", said Robert Verhagen, President … certain patients with non-small cell lung cancer ("NSCLC"). L-DOS47 is …